Health Consequences of Sarcopenic Obesity: A Narrative Review

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2020 Jun 9

PMID 32508753

Citations 102

Authors

Eun Roh

Kyung Mook Choi

Affiliations

Soon will be listed here.

Abstract

Sarcopenia is defined as the age-related loss of muscle mass and strength or physical performance. Increased amounts of adipose tissue often accompany sarcopenia, a condition referred to as sarcopenic obesity. The prevalence of sarcopenic obesity among adults is rapidly increasing worldwide. However, the lack of a universal definition of sarcopenia limits comparisons between studies. Sarcopenia and obesity have similar pathophysiologic factors, including lifestyle behaviors, hormones, and immunological factors, all of which may synergistically affect the risk of developing a series of adverse health issues. Increasing evidence has shown that sarcopenic obesity is associated with accelerated functional decline and increased risks of cardiometabolic diseases and mortality. Therefore, the identification of sarcopenic obesity may be critical for clinicians in aging societies. In this review, we discuss the effect of sarcopenic obesity on multiple health outcomes and its role as a predictor of these outcomes based on the components of sarcopenia, including muscle mass, muscle strength, and physical performance.

Citing Articles

Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women.

Park J, Chung Y, Song J, Kil K, Lee H, Chae J J Menopausal Med. 2025; 30(3):143-151.

PMID: 39829191 PMC: 11745730. DOI: 10.6118/jmm.24004.

Clinical outcome changes in sarcopenic obesity: a meta-analysis of exercise training methods.

Chen L, Zhou H, Gong Y, Tang Y, Su H, Zhang Z BMC Geriatr. 2025; 25(1):33.

PMID: 39815241 PMC: 11734427. DOI: 10.1186/s12877-024-05655-1.

Weight-Adjusted Waist Index (WWI)-A Promising Anthropometric Indicator of Depressive Symptoms in Hospitalized Older Patients.

Korycka-Bloch R, Balicki P, Guligowska A, Soltysik B, Kostka T, Chrzastek Z Nutrients. 2025; 17(1.

PMID: 39796502 PMC: 11722845. DOI: 10.3390/nu17010068.

Correlation and predictive value of novel anthropometric indicators with adult sarcopenia and sarcopenia obesity.

Wu X, Chen Z, Zhao Y, Ren H Sci Rep. 2024; 14(1):31776.

PMID: 39738342 PMC: 11685711. DOI: 10.1038/s41598-024-82751-7.

Predicting sarcopenia risk in stroke patients: a comprehensive nomogram incorporating demographic, anthropometric, and biochemical indicators.

Pu Y, Wang Y, Wang H, Liu H, Dou X, Xu J Front Neurol. 2024; 15:1438575.

PMID: 39717682 PMC: 11665213. DOI: 10.3389/fneur.2024.1438575.

References

Beaudart C, Rolland Y, Cruz-Jentoft A, Bauer J, Sieber C, Cooper C . Assessment of Muscle Function and Physical Performance in Daily Clinical Practice : A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif Tissue Int. 2019; 105(1):1-14. DOI: 10.1007/s00223-019-00545-w. View

Guralnik J, Ferrucci L, Pieper C, Leveille S, Markides K, Ostir G . Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000; 55(4):M221-31. DOI: 10.1093/gerona/55.4.m221. View

Kim B, Ahn S, Lee S, Hong S, Hamrick M, Isales C . Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study. Aging (Albany NY). 2019; 11(13):4547-4560. PMC: 6660042. DOI: 10.18632/aging.102068. View

Kim Y, Lee Y, Chung Y, Lee D, Joo N, Hong D . Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci. 2012; 67(10):1107-13. DOI: 10.1093/gerona/gls071. View

Zizza C, Herring A, Stevens J, Popkin B . Obesity affects nursing-care facility admission among whites but not blacks. Obes Res. 2002; 10(8):816-23. DOI: 10.1038/oby.2002.110. View

Sasaki H, Kasagi F, Yamada M, Fujita S . Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am J Med. 2007; 120(4):337-42. DOI: 10.1016/j.amjmed.2006.04.018. View

Prado C, Wells J, Smith S, Stephan B, Siervo M . Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr. 2012; 31(5):583-601. DOI: 10.1016/j.clnu.2012.06.010. View

Janssen I, Heymsfield S, Ross R . Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002; 50(5):889-96. DOI: 10.1046/j.1532-5415.2002.50216.x. View

Newman A, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M . Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003; 51(11):1602-9. DOI: 10.1046/j.1532-5415.2003.51534.x. View

10.

Davison K, Ford E, Cogswell M, Dietz W . Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc. 2002; 50(11):1802-9. DOI: 10.1046/j.1532-5415.2002.50508.x. View

11.

Marzetti E, Calvani R, Cesari M, Buford T, Lorenzi M, Behnke B . Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol. 2013; 45(10):2288-301. PMC: 3759621. DOI: 10.1016/j.biocel.2013.06.024. View

12.

Janssen I, Baumgartner R, Ross R, Rosenberg I, Roubenoff R . Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004; 159(4):413-21. DOI: 10.1093/aje/kwh058. View

13.

Kim T, Choi K . The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease. J Cell Biochem. 2014; 116(7):1171-8. DOI: 10.1002/jcb.25077. View

14.

Srikanthan P, Hevener A, Karlamangla A . Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One. 2012; 5(5):e10805. PMC: 3279294. DOI: 10.1371/journal.pone.0010805. View

15.

Despres J . Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012; 126(10):1301-13. DOI: 10.1161/CIRCULATIONAHA.111.067264. View

16.

Metter E, Lynch N, Conwit R, Lindle R, Tobin J, Hurley B . Muscle quality and age: cross-sectional and longitudinal comparisons. J Gerontol A Biol Sci Med Sci. 1999; 54(5):B207-18. DOI: 10.1093/gerona/54.5.b207. View

17.

Goodpaster B, Park S, Harris T, Kritchevsky S, Nevitt M, Schwartz A . The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006; 61(10):1059-64. DOI: 10.1093/gerona/61.10.1059. View

18.

Hamer M, Batty G, Kivimaki M . Sarcopenic obesity and risk of new onset depressive symptoms in older adults: English Longitudinal Study of Ageing. Int J Obes (Lond). 2015; 39(12):1717-20. PMC: 4722238. DOI: 10.1038/ijo.2015.124. View

19.

Procaccini C, Jirillo E, Matarese G . Leptin as an immunomodulator. Mol Aspects Med. 2011; 33(1):35-45. DOI: 10.1016/j.mam.2011.10.012. View

20.

Choi K . Sarcopenia and sarcopenic obesity. Korean J Intern Med. 2016; 31(6):1054-1060. PMC: 5094937. DOI: 10.3904/kjim.2016.193. View